Keywords: Brexafemme; Diflucan; Vivjoa; adverse effects; antifungals; dosage; drug interactions; efficacy; fluconazole; ibrexafungerp; lactation; oteseconazole; pregnancy; safety; vulvovaginal candidiasis.